Study points to a phosphorylation pathway that may contribute to the development of lung injury and fibrosis
A study by researchers at the University of California, San Diego School of Medicine may lead to a way to prevent the progression, or induce the regression, of lung injury that results from use of the anti-cancer chemotherapy drug Bleomycin… Read the full story from the UCSD Newsroom
The study investigators are Drs. Martina Buck and Mario Chojkier of the Division of Gastroenterology in the Department of Medicine and the Biomedical Sciences Program at UC San Diego and the VA San Diego Healthcare System. Martina Buck, PhD, is associate professor of medicine and Mario Chojkier, MD, is professor of medicine. | Read the report online in PLoS ONE
